Biotechs

Rediff.com » News » Biotechs

News for Biotechs

News
Business
Sports

Bharat Biotech finally names ICMR as co-owner in Covaxin patent filings

After reports claimed that filings in patent offices in India, the US, and Europe did not mention ICMR or its scientists, but only BBIL and its scientists, the Hyderabad-based biotechnology......

'Poorly designed': ICMR on BHU Covaxin safety study

The Indian Council of Medical Research Director General Dr Rajiv Bahl on Monday criticised a recently published study on the long-term safety analysis of the Covaxin in adults and adolescents for......

Should Govt Continue Covid Vax Drive?

India has covered enough population with vaccine and infection, but protein vaccines should remain available on payment basis for elderly and those with comorbidities. IMAGE: A healthcare worker......

Over 30% Covaxin takers reported adverse events: Study

Nearly one-third of 926 individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI, according to a one-year follow up study......

Trump triumphs in Iowa caucuses, heads for Biden rematch

Donald Trump scripted a decisive victory in the Iowa caucuses, cementing his status as the frontrunner for the 2024 Republican presidential nomination, a contest that also saw Indian-American......

'Expect formulations biz to outpace API biz'

'API prices are dragging down margins and impacting our competitive ability.' Photograph: Kind courtesy Biocon Biocon delves into the evolving dynamics of the biosimilar market, with a focus on......

India's IPO market set to break May jinx in Lok Sabha election year

‘Sell in May, go away’ is a popular market adage. But ‘Don’t sell any new shares in May’ is the best kept secret of Dalal Street that’s set to break.......

'The formulations business been a growth driver'

'Fundamentally, we think that in the coming quarters, API business should come back.' Photograph: Kind courtesy Biocon Biocon is preparing to make the most of the peptides opportunity as these......

'APIs are a very strategic part of Biocon's business'

'There is no reason why we should break this business up.' Photograph: Kind courtesy Biocon Bengaluru-headquartered biotech major Biocon has been working to reduce its cumulative debt of around......

Domestic MFs anchoring more listings as issue sizes shrink

Domestic mutual funds (MFs) have underpinned demand for most public floats this year, dominated by small- and mid-sized initial public offerings (IPOs). Illustration: Dominic Xavier/Rediff.com Of......

Djokovic-owned biotech firm developing COVID treatment

IMAGE: The biotech firm, in which Novak Djokovic has an 80 per cent stake, has around 11 researchers working in Denmark, Australia and Slovenia, working on a treatment and not a vaccine according......

Rediff News

Biotechs

News for Biotechs

Bharat Biotech finally names ICMR as co-owner in Covaxin patent filings

'Poorly designed': ICMR on BHU Covaxin safety study

Should Govt Continue Covid Vax Drive?

Over 30% Covaxin takers reported adverse events: Study

Trump triumphs in Iowa caucuses, heads for Biden rematch

'Expect formulations biz to outpace API biz'

India's IPO market set to break May jinx in Lok Sabha election year

'The formulations business been a growth driver'

'APIs are a very strategic part of Biocon's business'

Domestic MFs anchoring more listings as issue sizes shrink

Djokovic-owned biotech firm developing COVID treatment

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS